{"id":192201,"date":"2015-03-16T13:51:15","date_gmt":"2015-03-16T17:51:15","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/thomas-p-cappola-md-scm-named-chief-of-the-division-of-cardiovascular-medicine-at-the-perelman-school-of-medicine.php"},"modified":"2015-03-16T13:51:15","modified_gmt":"2015-03-16T17:51:15","slug":"thomas-p-cappola-md-scm-named-chief-of-the-division-of-cardiovascular-medicine-at-the-perelman-school-of-medicine","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/thomas-p-cappola-md-scm-named-chief-of-the-division-of-cardiovascular-medicine-at-the-perelman-school-of-medicine.php","title":{"rendered":"Thomas P. Cappola, MD, ScM, Named Chief of the Division of Cardiovascular Medicine at the Perelman School of Medicine &#8230;"},"content":{"rendered":"<p><p>Contact Information         <\/p>\n<p>      Available for logged-in reporters only    <\/p>\n<p>    Newswise  PHILADELPHIA  Thomas P. Cappola, MD, ScM, a    physician-scientist with special expertise in heart failure,    has been named chief of the division of Cardiovascular Medicine    at the Perelman School of Medicine at the University of    Pennsylvania.  <\/p>\n<p>    He will lead a division comprised of 78 faculty and 47 fellows,    overseeing both clinical care and research efforts across    cardiovascular specialties, including interventional    cardiology, electrophysiology, heart failure and    transplantation, adult congenital heart disease, consultative    cardiology, noninvasive imaging, preventive cardiology and    vascular medicine. The division cares for more than 68,000    patients each year.  <\/p>\n<p>    Dr. Cappola has proven himself to be a leader and innovator in    cardiovascular medicine, particularly in his field of advanced    heart failure and transplantation, said Michael S. Parmacek,    MD, chair of the department of Medicine, who preceded Dr.    Cappola as chief of the division of Cardiovascular Medicine. I    look forward to watching him build upon the foundation of    excellence in the division of Cardiovascular Medicine and    taking the program in exciting new directions.  <\/p>\n<p>    Cappola has served as an attending cardiologist on Penns    nationally recognized advanced heart failure and    transplantation service since his arrival at Penn in 2003. He    also served as associate director of the Cardiovascular    Medicine Fellowship Program from 2011 to 2013. That year, he    was appointed as director of the Hospital of the University of    Pennsylvania Clinical and Translational Research Center and    assistant director of the Institute for Translational Medicine    and Therapeutics (ITMAT). Dr. Cappola is also a member of    Penns Institute for Diabetes, Obesity, and Metabolism; the    Cardiovascular Institute; the Institute for Translational    Medicine and Therapeutics; and the Penn Genome Frontiers    Institute.  <\/p>\n<p>    Dr. Cappolas application of genomic methodologies to identify    the molecular and genetic basis of heart failure was recognized    in 2008 with a Presidential Early Career Award for Scientists    and Engineers (PECASE), which he received from President Obama.    This is the highest honor bestowed by the United States    government for scientists and engineers in the early stages of    their careers. To date, Dr. Cappola has published over 80    manuscripts and lectured extensively nationally and    internationally. Dr. Cappola currently serves as the    co-principal investigator of the National Heart Lung and Blood    Institute (NHLBI)-sponsored Mid-Atlantic Heart Failure Network.    He is also co-investigator for the Institutional Clinical and    Translational Science Award from the National Institutes of    Health (NIH)\/National Center for Advancing Translational    Sciences (NCATS). Dr. Cappola is a member of the American    Society of Clinical Investigation (ASCI) and the Interurban    Clinical Club, and is a fellow of the American Heart    Association.  <\/p>\n<p>    Dr. Cappola earned his bachelors degree in chemistry at    Princeton University in 1991, his medical degree at Harvard    Medical School in 1995, and his masters degree of science in    clinical investigation from the Bloomberg School of Public    Health at Johns Hopkins University in 2004. He performed his    internship and residency at Brigham and Womens Hospital and    completed his cardiology fellowship, including specialty    training in heart failure and transplantation, at Johns    Hopkins.  <\/p>\n<p>    ###  <\/p>\n<p>    Penn Medicine is one of the world's leading academic medical    centers, dedicated to the related missions of medical    education, biomedical research, and excellence in patient care.    Penn Medicine consists of the Raymond and Ruth Perelman School    of Medicine at the University of Pennsylvania (founded in 1765    as the nation's first medical school) and the University of    Pennsylvania Health System, which together form a $4.3 billion    enterprise.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Read this article:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.newswise.com\/articles\/view\/631210\/?sc=rsmn\/RK=0\/RS=kpsYebHhmIl4qQGpYaqv78Jx0NE-\" title=\"Thomas P. Cappola, MD, ScM, Named Chief of the Division of Cardiovascular Medicine at the Perelman School of Medicine ...\">Thomas P. Cappola, MD, ScM, Named Chief of the Division of Cardiovascular Medicine at the Perelman School of Medicine ...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Contact Information Available for logged-in reporters only Newswise PHILADELPHIA Thomas P.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/thomas-p-cappola-md-scm-named-chief-of-the-division-of-cardiovascular-medicine-at-the-perelman-school-of-medicine.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[35],"tags":[],"class_list":["post-192201","post","type-post","status-publish","format-standard","hentry","category-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/192201"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=192201"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/192201\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=192201"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=192201"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=192201"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}